Hans Klingemann

Hans Klingemann

Chief Tech/Sci/R&D Officer at IMMUNITYBIO, INC.

74 year
Health Technology
Consumer Services
Health Services

Profile

Hans Georg Klingemann was the founder of NantKwest, Inc. (founded in 2002) where he held the title of Director, Chief Medical & Scientific Officer from 2012 to 2015.
He is currently the Chief Science Officer–Cellular at ImmunityBio, Inc. Dr. Klingemann's former positions include being an Independent Non-Executive Director at Osiris Therapeutics, Inc. from 2012 to 2016, Director-Bone Marrow Transplant at Rush University Medical Center, Director at Bone Marrow & Cancer Foundation, Inc., and Director-Stem Cell Transplant at Tufts Medical Center, Inc.Dr. Klingemann obtained a doctorate degree from Philipps University of Marburg and the University of Würzburg Medical School.

Hans Klingemann active positions

CompaniesPositionStart
IMMUNITYBIO, INC. Chief Tech/Sci/R&D Officer -
All active positions of Hans Klingemann

Former positions of Hans Klingemann

CompaniesPositionEnd
OSIRIS THERAPEUTICS, INC. Director/Board Member 2016-06-10
Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member -
IMMUNITYBIO, INC. Founder -
See the detail of Hans Klingemann's experience

Training of Hans Klingemann

Philipps University of Marburg Doctorate Degree
University of Würzburg Medical School Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hans Klingemann's experience

Connections

35

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
IMMUNITYBIO, INC.

Health Technology

Private companies5

Health Technology

Health Technology

Health Services

Commercial Services

Health Services

See company connections
  1. Stock Market
  2. Insiders
  3. Hans Klingemann